Selcuk University, Faculty of Medicine, Department of Radiation Oncology, 42075 Konya, Turkey.
Phys Med. 2013 Nov;29(6):577-82. doi: 10.1016/j.ejmp.2012.11.002. Epub 2012 Dec 5.
The purpose of this study is to compare field-in-field radiotherapy (FIF) with conformal radiotherapy (CRT) in terms of dosimetric benefits for early stage endometrial cancer patients.
Ten consecutive early stage endometrial cancer patients who underwent adjuvant external beam radiotherapy were included in the study. For each patient, two different treatment plans were created. FIF and CRT plans were compared for doses in the planning target volume (PTV), the organ at risk (OAR) volumes including rectum, bladder, bowel, bilateral femurs and bone marrow, the dose homogeneity index, and the monitor unit counts required for the treatment.
The FIF technique significantly reduced the maximum dose of the PTV, rectum, bladder, bowel, left femur, right femur and bone marrow (p values were: <0.001, 0.031, 0.003, <0.001, 0.001, 0.001 and <0.001 respectively). When the OAR volumes irradiated with >30 and >45 Gy were compared, the results were in favor of the FIF technique. The volumes of rectum, bladder, bowel, left femur, right femur and bone marrow receiving more than the prescription dose of 45 Gy were significantly reduced with FIF technique (p values were 0.016, 0.039, 0.01, 0.04, 0.037 and 0.01 respectively). The dose homogeneity index (DHI) was significantly improved with FIF technique (p < 0.001).
FIF allowed more homogeneous dose distribution in the PTV and reduced the doses received by OAR. Considering the lower maximum doses in the OAR and PTV, FIF technique seems to be more advantageous than CRT during adjuvant radiotherapy for early stage endometrial cancer patients.
本研究旨在比较场中野放疗(FIF)与适形放疗(CRT)在早期子宫内膜癌患者的剂量学优势方面的差异。
本研究纳入了 10 例接受辅助外照射放疗的早期子宫内膜癌患者。为每位患者创建了两种不同的治疗计划。对 FIF 和 CRT 计划进行了比较,包括计划靶区(PTV)、危及器官(OAR)体积(包括直肠、膀胱、肠、双侧股骨和骨髓)、剂量均匀性指数以及治疗所需的监测器单位计数。
FIF 技术显著降低了 PTV、直肠、膀胱、肠、左股骨、右股骨和骨髓的最大剂量(p 值分别为:<0.001、0.031、0.003、<0.001、0.001 和 <0.001)。当比较 OAR 体积接受>30 和>45 Gy 照射时,结果有利于 FIF 技术。FIF 技术显著减少了直肠、膀胱、肠、左股骨、右股骨和骨髓接受>45 Gy 处方剂量的体积(p 值分别为 0.016、0.039、0.01、0.04、0.037 和 0.01)。剂量均匀性指数(DHI)显著改善(p<0.001)。
FIF 允许在 PTV 中实现更均匀的剂量分布,并降低 OAR 接受的剂量。考虑到 OAR 和 PTV 中的最大剂量较低,FIF 技术在早期子宫内膜癌患者的辅助放疗中似乎比 CRT 更具优势。